Search for other papers by Lucie Allard in
Google Scholar
PubMed
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
An 87-year-old woman was referred to our department for a 15 cm right-sided cervical tumor with bleeding and skin ulceration, developed on a 6 cm papillary thyroid carcinoma diagnosed two years earlier. Surprisingly, there were no other compressive symptoms. Unexpectedly, but successfully, total thyroidectomy and neck dissection were performed. There were no poorly differentiated or anaplastic components in the final histological analysis. Impressive dehiscence occurred shortly after surgery and was also successfully managed. Our case highlights the benefit of considering surgery in the context of a tertiary care center even for an apparent massive aggressive cervical mass and despite old age.
Search for other papers by Kirsten E. Stewart in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Devraj Srinivasan in
Google Scholar
PubMed
Search for other papers by Morna MacNeill in
Google Scholar
PubMed
Search for other papers by Lucy Wall in
Google Scholar
PubMed
Search for other papers by Iain J. Nixon in
Google Scholar
PubMed
). What Does This Case Report Add? This case illustrates a patient with locally advanced DTC treated with tyrosine kinase inhibitor (TKI) therapy, which markedly reduced tumour volume and allowed subsequent successful surgical resection without
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Min Ren in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianlan Yao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Longlong Bao in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Zhiting Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Ran Wei in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Qianming Bai in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Bo Ping in
Google Scholar
PubMed
Department of Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Cai Chang in
Google Scholar
PubMed
Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Search for other papers by Yu Wang in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoyan Zhou in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Search for other papers by Xiaoli Zhu in
Google Scholar
PubMed
populations, and ThyroSeq NGS assays are not available for Chinese patients. In the current study, we used a multigene NGS panel to detect targeted DNA mutations and RNA fusions in a large cohort of 1041 samples including FNA materials and surgical resections
Search for other papers by Irini S. Hadjisavva in
Google Scholar
PubMed
Search for other papers by Roberto Dina in
Google Scholar
PubMed
Search for other papers by Michael A. Talias in
Google Scholar
PubMed
Search for other papers by Panayiotis A. Economides in
Google Scholar
PubMed
malignant [ 3 , 5 , 6 , 7 ]. It is a simple, safe and most accurate method for selecting the patients who will need surgical resection or follow-up. Ultrasound-guided FNA (USgFNA) has improved diagnostic accuracy compared to FNA by palpation [ 8 , 9
Search for other papers by Zhen Gao in
Google Scholar
PubMed
Search for other papers by Hongtao Zhang in
Google Scholar
PubMed
Search for other papers by Lijuan Zhang in
Google Scholar
PubMed
Search for other papers by Huimin Yu in
Google Scholar
PubMed
Search for other papers by Xuemin Di in
Google Scholar
PubMed
Search for other papers by Zeyang Wang in
Google Scholar
PubMed
Search for other papers by Zezhou Liu in
Google Scholar
PubMed
Search for other papers by Aixia Sui in
Google Scholar
PubMed
Search for other papers by Juan Wang in
Google Scholar
PubMed
Search for other papers by Gaofeng Shi in
Google Scholar
PubMed
Established Facts The incidence of thyroid cancer has increased in almost every part of the world. Papillary thyroid carcinoma (PTC) is typically treated with surgical resection, even in recurrent cases. However, it is difficult to
University of Lille, Lille, France
Search for other papers by Benjamin Chevalier in
Google Scholar
PubMed
Search for other papers by Oriane Karleskind in
Google Scholar
PubMed
University of Lille, Lille, France
Search for other papers by Arnaud Jannin in
Google Scholar
PubMed
Search for other papers by Olivier Farchi in
Google Scholar
PubMed
Search for other papers by Catherine Vermaut in
Google Scholar
PubMed
CRIStAL UMR CNRS 9189, University of Lille, Villeneuve-d’Ascq, France
Search for other papers by Alexandre Escande in
Google Scholar
PubMed
Search for other papers by Clio Baillet in
Google Scholar
PubMed
University of Lille, Lille, France
Institut National de la Santé et de la Recherche Médicale (INSERM), European Genomic Institute for Diabetes (EGID), CHU Lille, Lille, France
Search for other papers by Stéphanie Espiard in
Google Scholar
PubMed
University of Lille, Lille, France
Institut National de la Santé et de la Recherche Médicale (INSERM), European Genomic Institute for Diabetes (EGID), CHU Lille, Lille, France
Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed
Search for other papers by Bruno Carnaille in
Google Scholar
PubMed
Department of Pathology, Lille University Hospital, Lille, France
University of Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France
Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
ATC patients with complete remission, mostly after multimodal treatment effective in downsizing the tumor for surgical resection. However, we chose to not include them in our table because of the absence of complete pathological response on
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Sara Donato in
Google Scholar
PubMed
Search for other papers by Mariana Horta in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Miguel Rito in
Google Scholar
PubMed
Search for other papers by Pedro Gomes in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
all thyroid malignancies. Despite its rarity, ATC is one of the most aggressive solid tumors in humans, with a median survival of 5–6 months ( 1 ). Historically, the standard treatment for ATC includes surgical resection, if feasible, followed by
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
was recorded. The hepatic SUVmax was used as the reference value. Based on 18 F-FDG PET/CT scan findings, if the hypermetabolic lesion was accessible, surgical resection was the preferred option. If surgery was not possible, external beam radiation
Search for other papers by Rémy Louvel in
Google Scholar
PubMed
Search for other papers by Nathalie Badois in
Google Scholar
PubMed
Search for other papers by Jerzy Klijanienko in
Google Scholar
PubMed
Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Search for other papers by Caroline Hoffmann in
Google Scholar
PubMed
a surgical resection of all the nodules and a total thyroidectomy extended to the surrounding infiltrated tissues (Supplementary Fig. 1, see section on supplementary materials given at the end of this article). Histologically, benign thyroid tissue
College of Medicine, Yonsei University, Seoul, Republic of Korea
Search for other papers by Jihwan Yoo in
Google Scholar
PubMed
Search for other papers by Hee Jun Kim in
Google Scholar
PubMed
Search for other papers by Seok Mo Kim in
Google Scholar
PubMed
Search for other papers by Hun Ho Park in
Google Scholar
PubMed
carcinoma types ( 1 ). However, 0.15–1.3% of patients with thyroid cancer develop brain metastasis with a median survival time of 4–33 months ( 2 , 3 , 4 , 5 , 6 ). The treatment options for such patients include surgical resection, stereotactic